|
|
| Model Number |
N/A |
| Medical Device Problem Code |
Failure to Fire (2610)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/18/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
As reported, part of the plug of a 5f exoseal vascular closure device (vcd) was pulled out and bleeding was observed at the puncture site when the device was removed.Manual compression was used to achieve hemostasis.There was no reported patient injury.There was no difficulty connecting the vascular sheath introducer with the exoseal vascular closure device (vcd), no resistance or friction was experienced while advancing the exoseal vcd through the sheath, and the sheath was not kinked or bent.The vascular sheath introducer was retracted until the hub engaged with the indicator wire cowling and locked against the handle assembly.An audible click was heard, pulsatile flow was observed from the bleed-back indicator, and the deployment button was fully depressed and flush against the handle.There was no issue with or damage to the deployment lever.The exoseal vcd and vascular sheath introducer were removed as a single unit approximately 1¿2 seconds after depressing the deployment button, and the plug was brought out when the device was removed.The indicator wire was not visible when the device was removed.A non-cordis catheter sheath introducer was used.Femoral artery suitability was verified on angiography, including the vascular sheath introducer insertion angle, and the vessel diameter was verified to be at least 5 mm.There was no visible calcium or plaque at the puncture site.There was no stent near the puncture site.There was no stenosis greater than 50% at or near the puncture site.The target femoral site had not been previously closed with a closure device or manual compression within 30 days before the procedure.There was no evidence of a pre-existing hematoma, arteriovenous fistula, or pseudoaneurysm at the access site before exoseal vcd use.The exoseal vcd was used in a diagnostic procedure using a retrograde approach.The patient¿s body mass index was not greater than 40.There were no visible signs of device/package damage prior to use.The physician had achieved certification for use of the exoseal vcd.The device was stored and prepared according to the instructions for use (ifu).The device will be returned for evaluation.
|
| |
|
Additional Manufacturer Narrative
|
|
Due to system limitations, section h6 required to input type of investigation, investigation findings, and investigation conclusions for an initial report.Pending additional information to complete investigation.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
|
| |
|
Search Alerts/Recalls
|
|
|